11 – 20 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Studies on signaling pathways induced by FLT3, an important oncogene in AML
(
- Thesis › Doctoral thesis (compilation)
- 2010
-
Mark
A conceptual framework for the identification of candidate drugs and drug targets in acute promyelocytic leukemia
(
- Contribution to journal › Article
-
Mark
Molecular mechanisms underlying deregulation of C/EBP alpha in acute myeloid leukemia
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status.
(
- Contribution to journal › Article
- 2006
-
Mark
Characterisation of the leukaemia-associated ETO homologues
2006)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Cyclin A1 Expression and Regulation in Hematopoietic and Leukemic Cells
(
- Thesis › Doctoral thesis (compilation)
- 2005
-
Mark
Gatekeeper pathways and cellular background in the pathogenesis and therapy of AML
(
- Contribution to journal › Scientific review
-
Mark
Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations
(
- Contribution to journal › Article
- 2003
-
Mark
Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study
(
- Contribution to journal › Article
-
Mark
More efficient mobilisation of peripheral blood stem cells with HiDAC plus AMSA plus G-CSF than with mini-ICE plus G-CSF in patients with AML
(
- Contribution to journal › Article